Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 Next Page Last Page
 
1
Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors - Figure 6: On the physiological role of antagonistic intramembrane A2A��D2 receptor interactions potentially existing in putative A2A��D2 heterodimers
2008-12-01

Figure 6: On the physiological role of antagonistic intramembrane A2A��D2 receptor interactions potentially existing in putative A2A��D2 heterodimers. Legend: A: illustration of the antagonistic intramembrane ...

NSDL National Science Digital Library

2
Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease.
2011-08-16

Huntington disease (HD) is a neurodegenerative disorder involving preferential loss of striatal GABAergic medium spiny neurons. Adenosine A(2A) receptors (A(2A)Rs) are present in the striatum at both presynaptic and post-synaptic levels. Blocking ...

PubMed

3
Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines.
2008-11-24

Antagonism of the adenosine A(2a) receptor offers great promise in the treatment of Parkinson's disease. In the course of exploring pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A(2A) antagonists, which led to clinical candidate SCH 420814, we ...

PubMed

4
Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors.
2006-06-21

Motor nerve terminals possess adenosine A(2A) receptors and brain derived neurotrophic factor (BDNF) TrkB receptors. In the present work we evaluated how BDNF actions on neuromuscular transmission would be influenced by adenosine ...

PubMed

5
Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors.
2007-01-01

We previously reported that adenosine, through A(2A) receptor activation, potentiates synaptic actions of brain-derived neurotrophic factor (BDNF) in the hippocampus of infant (3-4 weeks) rats. Since A(2A)-receptor-mediated actions ...

PubMed

6
Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts.
2010-07-11

In this paper we review some novel aspects related to the way adenosine A(2A) receptors (A(2A)R) modulate the action of BDNF or its high-affinity receptors, the TrkB receptors, on synaptic transmission and ...

PubMed

7
Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.
2011-05-23

Syntheses and physicochemical properties of N-cycloalkyl-substituted imidazo-, pyrimido- and 1,3-diazepino[2,1-f]purinediones are described. These derivatives were synthesized by cyclization of 7-halogenoalkyl-8-bromo-1,3-dimethylxanthine derivatives with aminocycloalkanes. The obtained compounds (1-33) were evaluated for their affinity to rat adenosine A(1) and A(2A) ...

PubMed

8
Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors - Figure 5: Antagonistic A2A��D2 receptor interactions and an inhibitory allosteric modulator homocysteine may exist in the control of D2 receptor signaling in putative A2A��D2 heterodimers of the striatopallidal GABA neurons
2008-12-01

Figure 5: Antagonistic A2A��D2 receptor interactions and an inhibitory allosteric modulator homocysteine may exist in the control of D2 receptor signaling in putative A2A��D2 heterodimers of the striatopallidal GABA neurons. ...

NSDL National Science Digital Library

9
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.
2010-03-07

Two reactive metabolites were identified in vivo for the dual A(2A)/A(1) receptor antagonist 1. Two strategies were implemented to successfully mitigate the metabolic liabilities associated with 1. Optimization of the arylindenopyrimidines led to a number of amide, ether, and amino analogs having comparable in ...

PubMed

10
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
2008-03-30

The (-)-(11R,2'S)-enantiomer of the antimalarial drug mefloquine has been found to be a reasonably potent and moderately selective adenosine A(2A) receptor antagonist. Further investigation of this compound has led to the discovery of a series of keto-aryl thieno[3,2-d]pyrimidine derivatives, which are potent and ...

PubMed

11
Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens.
2011-07-01

Caffeine, the most widely used psychoactive compound, is an adenosine receptor antagonist. It promotes wakefulness by blocking adenosine A(2A) receptors (A(2A)Rs) in the brain, but the specific neurons on which caffeine acts to ...

PubMed

12
A2A receptors in inflammation and injury: lessons learned from transgenic animals.
2007-12-26

Adenosine regulates the function of the innate and adaptive immune systems through targeting virtually every cell type that is involved in orchestrating an immune/inflammatory response. Of the four adenosine receptors (A(1), A(2A), A(2B), A(3)), A(2A) ...

PubMed

13
Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders.
2010-07-23

Parkinson's Disease (PD) and Extrapyramidal Syndrome (EPS) are movement disorders that result from degeneration of the dopaminergic input to the striatum and chronic inhibition of striatal dopamine D(2) receptors by antipsychotics, respectively. Adenosine A(2A) receptors are selectively ...

PubMed

14
Low Ethanol Sensitivity and Increased Ethanol Consumption in Mice Lacking Adenosine A2A Receptors

Low Ethanol Sensitivity and Increased Ethanol Consumption in Mice Lacking Adenosine A2A Receptors2AR / ) mice. In the present report, we further characterize the role of adenosine A2A receptors be- tween the two genotypes. The ...

E-print Network

15
Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.
2010-11-04

Several recent studies suggest functional and molecular interactions between striatal adenosine A(2A) and cannabinoid CB(1) receptors. Here, we demonstrate that A(2A) receptors selectively modulate reinforcing effects of cannabinoids. We studied effects of A(2A) receptor ...

PubMed

16
Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine.
2008-02-08

The excitatory action of brain-derived neurotrophic factor (BDNF) on synaptic transmission is triggered by adenosine A2A receptor activation. Since high-frequency neuronal firing, such as that inducing long-term potentiation (LTP), favours both ...

PubMed

17
Spinal adenosine A2(A) receptor inhibition enhances phrenic long term facilitation following acute intermittent hypoxia.
2009-11-09

Phrenic long term facilitation (pLTF) is a form of respiratory plasticity induced by acute intermittent hypoxia. pLTF requires spinal serotonin receptor activation, new BDNF synthesis and TrkB receptor activation. Spinal adenosine 2A (A(2A)) ...

PubMed

18
Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
2008-06-04

Adenosine A(2A) and dopamine D(2) receptors (A(2A) and D(2)) associate in homo- and heteromeric complexes in the striatum, providing a structural basis for their mutual antagonism. At the cellular level, the portion of receptors ...

PubMed

19
In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease.
2010-10-25

The in vivo characterization of a dual adenosine A(2A)/A(1) receptor antagonist in several animal models of Parkinson's disease is described. Discovery and scale-up syntheses of compound 1 are described in detail, highlighting optimization steps that increased the overall yield of 1 from 10.0% to 30.5%. Compound 1 ...

PubMed

20
Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.
2010-12-02

An interaction between adenosine A(2A) receptors (A(2A) Rs) and cannabinoid CB(1) receptors (CB(1) Rs) has been consistently reported to occur in the striatum, although the precise mechanisms are not completely understood. As both ...

PubMed

First Page Previous Page 1 2 Next Page Last Page
 
First Page Previous Page 1 2 Next Page Last Page
 
21
Antiparkinsonian effects of novel adenosine A(2A) receptor antagonists.
2010-11-18

The present work describes the synthesis of a pyrazinopurinedione derivative which was together with a series of pyrimidopurinedione derivatives tested for potential antiparkinsonian activity in two tests: the "oxotremorine" and the "reserpine" test. For the studies compounds which had shown affinity for the adenosine ...

PubMed

22
Robert A. Peterfreund (Wylie Vale / Neuroscience)

organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses. Brain Res. 2004 Mar, Peterfreund RA, Fuxe K, Vincent JD, Lledo PM. Activation of adenosine A1 and A2A receptors modulates dopamine, Gies EK, Gelb CR, Peterfreund RA. Agonist-induced ...

E-print Network

23
Structure of an agonist-bound human A2A adenosine receptor.
2011-03-10

Activation of G protein-coupled receptors upon agonist binding is a critical step in the signaling cascade for this family of cell surface proteins. We report the crystal structure of the A(2A) adenosine receptor (A(2A)AR) bound to an agonist UK-432097 at 2.7 angstrom ...

PubMed

24
TRKing Signals Through the Golgi
2005-01-18

The subcellular localization of transmembrane receptors and other signaling proteins has emerged as a key component in the regulation of the intensity and specificity of their activity. Recent research indicates that immature TrkA neurotrophin receptors are transactivated in the Golgi apparatus after stimulation of neuropeptide ...

NSDL National Science Digital Library

25
Functional coupling of adenosine A2a receptor to inhibition of the mitogen-activated protein kinase cascade in Chinese hamster ovary cells.
1996-05-15

Activation of Gs-coupled receptors enhances the increase in cyclic AMP mediated by adenylate cyclases. As it has been shown that cyclic AMP inhibits the epidermal growth factor-activated mitogen-activated protein kinase (MAPK) signalling pathway, stimulation of Gs-coupled receptors may lead to ...

PubMed

First Page Previous Page 1 2 Next Page Last Page